Nedocromil
From Wikipedia, the free encyclopedia
 |
|
|
Nedocromil
|
|
| Systematic (IUPAC) name | |
| 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro- 4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid |
|
| Identifiers | |
| CAS number | 69049-73-6 |
| ATC code | R01AC07 R03BC03, S01GX04 |
| PubChem | 50294 |
| DrugBank | APRD01137 |
| Chemical data | |
| Formula | C19H17NO7 |
| Mol. weight | 371.341 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 89% |
| Metabolism | not metabolized |
| Half life | ~3.3 hours |
| Excretion | excreted unchanged |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
POM(UK) |
| Routes | Inhalation and eye drops |
Nedocromil sodium is a medication used to prevent wheezing, shortness of breath, and other breathing problems caused by asthma. It is administered by an inhaler under the brand name Tilade®.
Nedocromil is classified as a cromone. Nedocromil acts as a mast cell stabilizer, reducing the release of inflammatory mediators such as histamine from mast cells.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
| Medications commonly used in asthma and COPD (primarily R03) edit | ||
|---|---|---|
| Anticholinergics: | ||
| Short acting β2-agonists: | ||
| Long acting β2-agonists (LABA): | Clenbuterol, Formoterol, Salmeterol | |
| Corticosteroids: | ||
| Leukotriene antagonists: | ||
| Xanthines: | ||
| Mast cell stabilizers: |
Cromoglicate, Nedocromil |
|
| Combination products: |
Budesonide/formoterol, Fluticasone/salmeterol, Ipratropium/salbutamol |
|
